Back
Johnson & Johnson Vs. AbbVie Industry Stock Comparison
Sell
41
JNJ
Johnson & Johnson
Last Price:
160.27
Seasonality Move:
4.58%
Sell
39
ABBV
AbbVie
Last Price:
194.26
Seasonality Move:
12.18%
Sell
41
Johnson & Johnson (JNJ)
is a Sell
Is Johnson & Johnson a Buy, Sell or Hold?
- The current Johnson & Johnson [JNJ] share price is $160.29. The Score for JNJ is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- JNJ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
AbbVie (ABBV)
is a Sell
Is AbbVie a Buy, Sell or Hold?
- The current AbbVie [ABBV] share price is $194.29. The Score for ABBV is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- ABBV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
JNJ Stock Price Chart
What is Johnson & Johnson's stock price today?
-
The Johnson & Johnson share price today is $160.29
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JNJ is experiencing buying pressure, which is a positive indicator for future bullish movement.
ABBV Stock Price Chart
JNJ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.57 | Sell |
| Relative Strength Index (14 RSI): | 39.83 | Sell |
| Chaikin Money Flow: | 3992782 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (161.77 - 166.49) | Sell |
| Bollinger Bands (100): | (148.27 - 163.25) | Buy |
ABBV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.81 | Buy |
| Relative Strength Index (14 RSI): | 50.76 | Buy |
| Chaikin Money Flow: | -191765 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (192.9 - 196.8) | Sell |
| Bollinger Bands (100): | (166.36 - 194) | Buy |
JNJ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 161.18 | Sell |
| 20-day SMA: | 163.68 | Sell |
| 50-day SMA: | 162.5 | Sell |
| 200-day SMA: | 155.83 | Buy |
| 8-day EMA: | 161.46 | Sell |
| 20-day EMA: | 162.57 | Sell |
| 50-day EMA: | 161.2 | Sell |
| 200-day EMA: | 157.19 | Buy |
ABBV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 194.87 | Sell |
| 20-day SMA: | 194.7 | Sell |
| 50-day SMA: | 193.13 | Buy |
| 200-day SMA: | 174.54 | Buy |
| 8-day EMA: | 195.12 | Sell |
| 20-day EMA: | 194.6 | Sell |
| 50-day EMA: | 190.81 | Buy |
| 200-day EMA: | 175.34 | Buy |
Johnson & Johnson Earnings Growth & JNJ Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.56 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.07 per share, and an increase next year of $0.72 per share.
AbbVie Earnings Growth & ABBV Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.26 per share, and an increase next year of $1.21 per share.
Johnson & Johnson Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
AbbVie Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||